Search

everythinglearnresearchcommunity

for

Search:↓

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

The new compound may be a safer alternative to finasteride for prostate protection.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

A natural steroid in the body may protect against eye damage in glaucoma.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

GD-23 reduces anxiety by relying on neurosteroid production.

Medications for benign prostatic syndrome can cause cognitive issues and depression.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Midazolam's seizure prevention is partly due to increased neurosteroid production.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Certain drugs change freshwater snail shells to a "banana" shape.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Latanoprost eye drops may cause skin depigmentation.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Finasteride may help reduce impulsivity caused by pramipexole.

A new compound may treat benign prostatic hyperplasia better than finasteride.

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.